drugset / Trial / NCT02557685

Gut Microbiota Changes After Fecal Microbiota Transplantation

NCT02557685

Phase 2 Unknown 6 enrolled The Miriam Hospital
NaSingle-groupOpen-labelTreatment

Summary

This study aims to document early changes in the distal gut microbiota (both fecal and mucosa-associated) post FMT. Furthermore, whole blood and urine samples will facilitate collaborative immunologic and metabolomic analyses. This will be an open label clinical trial of FMT to prevent further recurrence in patients who have suffered at least a third episode of Clostridium difficile infection (CDI) and who have previously been treated with oral vancomycin.

Timeline

Start
2015-06
Primary completion
2016-03
Completion
2017-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ornidazole Other / unclassified 300 ml Other